BCR-ABL1 expression in multiple myeloma cells: A case of mistaken identity?

被引：4
|
作者：
MacLeod, Roderick A. F. [1 ]
Nagel, Stefan [1 ]
Dirks, Wilhelm [1 ]
Drexler, Hans G. [1 ]
机构：
[1] Leibniz Inst DSMZ, Dept Human & Anim Cell Cultures, D-38124 Braunschweig, Germany
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 04期
关键词：
LEUKEMIA; LINES;
D O I：
10.1073/pnas.1219862110
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：E270 / E271
页数：2
相关论文
共 50 条
  • [21] Screening for BCR-ABL1 in Patients with an Isolated Eosinophilia
    Langabeer, Stephen E.
    CLINICAL LABORATORY, 2016, 62 (10) : 2073 - 2074
  • [22] Genetic Events Other than BCR-ABL1
    Paolo Neviani
    Current Hematologic Malignancy Reports, 2014, 9 : 24 - 32
  • [23] A review of the challenge in measuring and standardizing BCR-ABL1
    Yu, Shuping
    Cui, Ming
    He, Xiao
    Jing, Rongrong
    Wang, Huimin
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (10) : 1465 - 1473
  • [24] Chronic Myeloid Leukemia: Beyond BCR-ABL1
    Ting Zhou
    L. Jeffrey Medeiros
    Shimin Hu
    Current Hematologic Malignancy Reports, 2018, 13 : 435 - 445
  • [25] Report of Canonical BCR-ABL1 Fusion in Glioblastoma
    Pang, Ying
    Yu, Guangyang
    Butler, Madison
    Sindiri, Sivasish
    Song, Young K.
    Wei, Jun S.
    Wen, Xinyu
    Chou, Hisen-Chao
    Quezado, Martha
    Pack, Svetlana
    Xi, Liqiang
    Abdullaev, Zied
    Kim, Olga
    Ranjan, Alice
    Merchant, Mythili
    Antony, Ramya
    Boris, Lisa
    Aboud, Orwa
    Kamson, David
    Kaplan, Rosandra
    Mackey, Megan
    Camphausen, Kevin
    Zaghloul, Kareem
    Armstrong, Terri S.
    Gilbert, Mark R.
    Aldape, Kenneth
    Holdhoff, Matthias
    Khan, Javed
    Wu, Jing
    JCO PRECISION ONCOLOGY, 2021, 5 : 1348 - 1353
  • [26] Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline
    Branford, Susan
    Yeung, David T.
    Parker, Wendy T.
    Roberts, Nicola D.
    Purins, Leanne
    Braley, Jodi A.
    Altamura, Haley K.
    Yeoman, Alexandra L.
    Georgievski, Jasmina
    Jamison, Bronte A.
    Phillis, Stuart
    Donaldson, Zoe
    Leong, Mary
    Fletcher, Linda
    Seymour, John F.
    Grigg, Andrew P.
    Ross, David M.
    Hughes, Timothy P.
    BLOOD, 2014, 124 (04) : 511 - 518
  • [27] The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib
    Parker, Wendy T.
    Yeung, David T. O.
    Yeoman, Alexandra L.
    Altamura, Haley K.
    Jamison, Bronte A.
    Field, Chani R.
    Hodgson, J. Graeme
    Lustgarten, Stephanie
    Rivera, Victor M.
    Hughes, Timothy P.
    Branford, Susan
    BLOOD, 2016, 127 (15) : 1870 - 1880
  • [28] MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression
    Chen Huan
    Lou Jin
    Wang Heng
    An Na
    Pan Yuming
    Du Xin
    Zhang Qiaoxia
    LEUKEMIA RESEARCH, 2018, 75 : 1 - 6
  • [29] Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
    Smith, Brittany M.
    Brewer, Diana
    Druker, Brian J.
    Braun, Theodore P.
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1707 - 1711
  • [30] BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML
    Bazeos, Alexandra
    Marin, David
    Gerrard, Gareth
    Szydlo, Richard
    Milojkovic, Dragana
    Reid, Alistair
    de Lavallade, Hugues
    Apperley, Jane F.
    Goldman, John M.
    Foroni, Letizia
    Khorashad, Jamshid Sorouri
    BLOOD, 2009, 114 (22) : 1258 - 1258
12345